The hydrocodone question Asking whether hydrocodone should be rescheduled is only the beginning. FDA approves NSAID to address dose-related safety concerns October 22, 2013 By Formulary Staff FDA has approved diclofenac (Zorvolex, Iroko Pharmaceuticals) capsules, a nonsteroidal anti-inflammatory drug (NSAID), for the treatment of mild-to-moderate acute pain in adults. OTC pain meds as good as Rxs after tonsillectomy October 08, 2013 By Lisa Hack Over-the-counter (OTC) pain relievers are just as effective as prescription pain medications for posttonsillectomy pain, say researchers from Henry Ford Hospital. Pain control requires multidisciplinary approach September 01, 2013 By Jill Sederstrom Prevalence of chronic pain can add up to higher costs in mental-health and medical claims New bipartisan bill seeks to reclassify hydrocodone April 15, 2013 Will FDA classify hydrocodone as Schedule III, Schedule II, or somewhere in between? FDA warns about codeine for childrens’ postop pain February 26, 2013 By From Staff Reports FDA is adding its strongest warning to labels of codeine-containing products advising against their use for pain relief in children after surgery to remove tonsils or adenoids. The agency asks healthcare professionals to use alternate pain relievers instead. Ethics and pain A new bimonthly column from Ken Baker looks at ethical decision-making in pharmacy.